Bristol Myers Squibb CEO: Richest product pipeline we've had in the last decade

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

Pharma exec won't commit to selling life-saving drug in U.S. for lower price offered in Canada

Bristol-Myers Squibb Company (NYSE: BMY) Rings The Closing Bell®

Siddhart Nahata & Christopher Boerner – Morgan Stanley Global Healthcare Conference 2025

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

Bristol Myers Squibb | Global Patient Week 2023: LinkedIn Live